United States securities and exchange commission logo





                          July 6, 2021

       David Young, Pharm.D., Ph.D.
       Chief Executive Officer
       Processa Pharmaceuticals, Inc.
       7380 Coca Cola Drive, Suite 106
       Hanover, MD 21076

                                                        Re: Processa
Pharmaceuticals, Inc.
                                                            Registration
Statement on Form S-3
                                                            Filed June 30, 2021
                                                            File No. 333-257558

       Dear Dr. Young:

              This is to advise you that we have not reviewed and will not
review your registration
       statement.

               Please refer to Rules 460 and 461 regarding requests for
acceleration. We remind you
       that the company and its management are responsible for the accuracy and
adequacy of their
       disclosures, notwithstanding any review, comments, action or absence of
action by the staff.

                                                        Please contact
Christine Westbrook at 202-551-5019 with any questions.




                          Sincerely,


                          Division of Corporation Finance

                          Office of Life Sciences
       cc:                                              John J. Wolfel, Esq.